Results of those studies revealed that epithelial-mesenchymal transition, EGF pathway activation, and MET amplification are all significantly associated with increased invasion and migration in lung adenocarcinoma cells resistant to EGFR-TKI. Here, EGFR is linked to lung adenocarcinoma.